¥1,353.00
0.22%
Tokyo, Sep 28, 02:12 pm JST. Closed.
ISIN
JP3486150000
Symbol
4577

Daito Pharmaceutical Co.,ltd. Stock price

¥1,350.00
-1.00 0.07% 1M
-95.00 6.57% 6M
-6.00 0.44% YTD
+108.00 8.70% 1Y
+183.00 15.68% 3Y
-221.21 14.08% 5Y
+290.62 27.43% 10Y
+733.43 118.95% 20Y
Tokyo, Closing price Mon, Sep 28 2026
+0.00 0.00%
ISIN
JP3486150000
Symbol
4577
Industry

Is Daito Pharmaceutical Co.,ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
¥38.9b
Enterprise Value
¥47.3b
Net debt
¥8.3b
Cash
¥954.0m
Shares outstanding
28.7m
Valuation (TTM | estimate)
P/E
12.3
P/S
0.8 | 0.7
EV/Sales
0.9 | 0.9
EV/FCF
11.3
P/B
0.7
Dividends
DPS
¥45.00
Yield 1Y | 5Y
3.3% | 3.1%
Growth 1Y | 5Y
12.5% | 14.7%
Payout 1Y | 3Y
37.2% | 38.2%
Increased
8 Years
Financials (TTM | estimate)
Revenue
¥50.7b | ¥54.5b
EBITDA
¥8.0b
EBIT
¥3.6b
Net Income
¥3.2b
Free Cash Flow
¥4.2b
Growth (TTM | estimate)
Revenue
0.0% | 7.7%
EBITDA
15.4%
EBIT
38.9%
Net Income
65.7%
Free Cash Flow
470.2%
Margin
Gross
19.5%
EBITDA
15.8%
EBIT
7.2%
Net
6.2%
Free Cash Flow
8.3%
Financial Health
Equity Ratio
72.2%
Return on Equity
6.0%
ROCE
6.1%
ROIC
4.5%
Debt/Equity
0.2
More
EPS
¥109.8
FCF per Share
¥145.8
Short interest
-
Employees
1k
Rev per Employee
¥47.2m

Daito Pharmaceutical Co.,ltd. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Daito Pharmaceutical Co.,ltd. forecast:

3x Hold
43%
4x Sell
57%

Analyst Opinions

7 Analysts have issued a Daito Pharmaceutical Co.,ltd. forecast:

Hold
43%
Sell
57%

Financial data from Daito Pharmaceutical Co.,ltd.

May '26
+/-
%
50,650 50,650
0% 0%
100%
- Direct Costs 40,753 40,753
3% 3%
80%
9,897 9,897
15% 15%
20%
- Selling and Administrative Expenses 6,260 6,260
4% 4%
12%
- Research and Development Expense - -
-
-
8,024 8,024
15% 15%
16%
- Depreciation and Amortization 4,387 4,387
1% 1%
9%
EBIT (Operating Income) EBIT 3,637 3,637
39% 39%
7%
Net Profit 3,161 3,161
66% 66%
6%

In millions JPY.

Don't miss a Thing! We will send you all news about Daito Pharmaceutical Co.,ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Daito Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Toyama-Shi, Toyama-Ken and currently employs 1,073 full-time employees. The company went IPO on 2010-03-24. The firm is primarily engaged in the pharmaceutical business segment. The main products are active pharmaceutical ingredients and formulations. The firm manufactures, sells, purchases and sells active pharmaceutical ingredients, which are raw materials used to manufacture pharmaceuticals, and undertakes contract manufacturing. The firm also manufactures, sells, purchases and sells formulations of prescription drugs and over-the-counter drugs, and undertakes contract manufacturing.

Head office Japan
CEO Mr. Ohtsuga
Employees 1,073
Website www.daitonet.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today